DS
ASPN icon

David Shaw’s Aspen Aerogels ASPN Stock Holding History

David Shaw’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.76M Buy
1,066,501
+232,929
+28% +$1.14M ﹤0.01% 2166
2026
Q1 		$2.85M Buy
833,572
+810,355
+3,490% +$2.73M ﹤0.01% 2632
2025
Q4 		$65.7K Buy
23,217
+9,995
+76% +$51.5K ﹤0.01% 4423
2025
Q3 		$92K Sell
13,222
-7,500
-36% -$52.9K ﹤0.01% 4352
2025
Q2 		$123K Sell
20,722
-4,067
-16% -$23.4K ﹤0.01% 4110
2025
Q1 		$158K Buy
+24,789
New +$239K ﹤0.01% 3962
2024
Q4 		– Sell
-22,465
Closed -$622K – 4401
2024
Q3 		$622K Sell
22,465
-519,040
-96% -$13M ﹤0.01% 3581
2024
Q2 		$12.9M Buy
+541,505
New +$12.7M 0.01% 1171
2023
Q2 		– Sell
-77,788
Closed -$580K – 4221
2023
Q1 		$580K Sell
77,788
-141,488
-65% -$1.41M ﹤0.01% 3481
2022
Q4 		$2.59M Sell
219,276
-131,192
-37% -$1.5M ﹤0.01% 2715
2022
Q3 		$3.23M Buy
350,468
+148,472
+74% +$1.8M ﹤0.01% 2554
2022
Q2 		$2M Buy
+201,996
New +$4.08M ﹤0.01% 3080

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

David Shaw's ASPN Position: Q2 2026 in Review

David Shaw increased its Aspen Aerogels (ASPN) stake by 28% in Q2 2026, buying an estimated $1.14M and bringing the position to 1,066,501 shares worth $6.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

David Shaw first reported a position in ASPN in Q2 2022 and has held it in 12 quarters since. The position peaked at $12.9M in Q2 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • David Shaw held 1,066,501 shares of Aspen Aerogels worth $6.76M as of Q2 2026.
  • David Shaw bought 232,929 Aspen Aerogels shares in Q2 2026, an estimated $1.14M.
  • Aspen Aerogels made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2166 holding.
  • David Shaw first reported a position in Aspen Aerogels in Q2 2022 and has held it in 12 quarters since.
  • David Shaw's Aspen Aerogels position peaked at $12.9M in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.